Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations
about
From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS).Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view.5-Azacytidine-mediated hMSC behavior on electrospun scaffolds for skeletal muscle regeneration.Bioavailability enhancement and pharmacokinetic profile of an anticancer drug ibrutinib by self-nanoemulsifying drug delivery system.Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems.Biopharmaceutical insights of particulate emulsified systems - a prospective overview.Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations.
P2860
Q38916539-BEC17D7B-0D84-497A-9678-B3338298DE4BQ38967883-932818ED-9C93-4335-A112-93C8D90557D1Q50871994-89394EF1-13FA-4668-BD1C-99950BBD2CD9Q50915260-3567D62C-33FC-4F89-9062-3B9DA70980EBQ52663431-47F45AE2-EAEA-454C-BFB3-202B38267A5FQ55004938-5214CB95-945C-4C97-A558-DEA9B8B092D9Q55279087-CC09A1F1-53BF-41A6-A565-CE93138F9462
P2860
Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacokinetic aspects and in ...... l for lipid-based formulations
@ast
Pharmacokinetic aspects and in ...... l for lipid-based formulations
@en
Pharmacokinetic aspects and in ...... l for lipid-based formulations
@nl
type
label
Pharmacokinetic aspects and in ...... l for lipid-based formulations
@ast
Pharmacokinetic aspects and in ...... l for lipid-based formulations
@en
Pharmacokinetic aspects and in ...... l for lipid-based formulations
@nl
prefLabel
Pharmacokinetic aspects and in ...... l for lipid-based formulations
@ast
Pharmacokinetic aspects and in ...... l for lipid-based formulations
@en
Pharmacokinetic aspects and in ...... l for lipid-based formulations
@nl
P2860
P1476
Pharmacokinetic aspects and in ...... l for lipid-based formulations
@en
P2093
Rajesh Kumar Gandhi
Sivacharan Kollipara
P2860
P304
P356
10.1016/J.APSB.2014.09.001
P407
P577
2014-10-01T00:00:00Z